2025
Polygenic Susceptibility to Diabetes and Poor Glycemic Control in Stroke Survivors
Demarais Z, Conlon C, Rivier C, Clocchiatti-Tuozzo S, Renedo D, Torres-Lopez V, Sheth K, Meeker D, Zhao H, Ohno-Machado L, Acosta J, Huo S, Falcone G. Polygenic Susceptibility to Diabetes and Poor Glycemic Control in Stroke Survivors. Neurology 2025, 104: e210276. PMID: 39889253, DOI: 10.1212/wnl.0000000000210276.Peer-Reviewed Original ResearchConceptsStroke survivorsWorse glycemic controlPoor glycemic controlStroke patientsAssociated with worse glycemic controlGlycemic controlPolygenic risk scoresClinical management of stroke patientsAssociated with poor glycemic controlManagement of stroke patientsCross-sectional designGenetic association studiesUncontrolled diabetesSusceptibility to T2DMUK BiobankType 2 diabetes mellitusAdverse vascular outcomesRisk scoreAssociation studiesHemoglobin A1cSurvivorsVascular outcomesSusceptibility to diabetesStrokeDiabetes
2022
Association Between Rental Assistance Programs and Hemoglobin A1c Levels Among US Adults
Fenelon A, Lipska KJ, Denary W, Blankenship KM, Schlesinger P, Esserman D, Keene DE. Association Between Rental Assistance Programs and Hemoglobin A1c Levels Among US Adults. JAMA Network Open 2022, 5: e2222385. PMID: 35857325, PMCID: PMC9301513, DOI: 10.1001/jamanetworkopen.2022.22385.Peer-Reviewed Original ResearchConceptsUS adultsWaitlist groupCohort studyUncontrolled diabetesDiabetes outcomesMean blood glucose levelHemoglobin A1c levelsNutrition Examination SurveyImproved diabetes outcomesBlood glucose levelsOlder US adultsA1c levelsPrimary outcomeDiabetes controlExamination SurveyGlycated hemoglobinBlood glucoseNational HealthGlucose levelsMAIN OUTCOMEHealth StatisticsLogistic regressionCut pointsAdultsOutcomes
2021
Glycemic control and management of cardiovascular risk factors among adults with diabetes in the Eastern Caribbean Health Outcomes Research Network (ECHORN) Cohort Study
Hassan S, Magny-Normilus C, Galusha D, Adams OP, Maharaj RG, Nazario CM, Nunez M, Nunez-Smith M, Group O. Glycemic control and management of cardiovascular risk factors among adults with diabetes in the Eastern Caribbean Health Outcomes Research Network (ECHORN) Cohort Study. Primary Care Diabetes 2021, 16: 107-115. PMID: 34253484, PMCID: PMC8743302, DOI: 10.1016/j.pcd.2021.06.011.Peer-Reviewed Original ResearchConceptsEastern Caribbean Health Outcomes Research Network (ECHORN) Cohort StudyGlycemic controlCVD riskCohort studyRisk factorsCVD risk factor managementElevated CVD riskCardiovascular risk factorsCVD risk factorsRisk factor managementCVD risk equationsYears of agePercent of participantsCardiovascular riskIndependent predictorsUncontrolled diabetesPhysical examFactor managementHigh burdenHigh prevalencePremature mortalityMultinomial logistic regressionDiabetesRisk equationsBivariate analysis
2020
The Promise of Patient Portals for Individuals Living With Chronic Illness: Qualitative Study Identifying Pathways of Patient Engagement
Stewart M, Hogan T, Nicklas J, Robinson S, Purington C, Miller C, Vimalananda V, Connolly S, Wolfe H, Nazi K, Netherton D, Shimada S. The Promise of Patient Portals for Individuals Living With Chronic Illness: Qualitative Study Identifying Pathways of Patient Engagement. Journal Of Medical Internet Research 2020, 22: e17744. PMID: 32706679, PMCID: PMC7395248, DOI: 10.2196/17744.Peer-Reviewed Original ResearchConceptsPatient engagementPatient portalsPatient-provider communicationElectronic patient portalPatient-provider relationshipHealth care teamSecure messagingOnline health portalsSemistructured telephone interviewsUncontrolled diabetesDiabetes controlChronic conditionsMedical recordsNew symptomsCare teamChronic illnessMedical appointmentsPatient involvementPatientsDiabetesQualitative studyPatient accessTelephone interviewsCareHealth careStudy EV-103: New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab in locally advanced or metastatic urothelial cancer.
Mar N, Friedlander T, Hoimes C, Flaig T, Bilen M, Balar A, Henry E, Srinivas S, Rosenberg J, Petrylak D, Burgess E, Merchan J, Tagawa S, Carret A, Steinberg J, Chaney M, Milowsky M. Study EV-103: New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab in locally advanced or metastatic urothelial cancer. Journal Of Clinical Oncology 2020, 38: tps5092-tps5092. DOI: 10.1200/jco.2020.38.15_suppl.tps5092.Peer-Reviewed Original ResearchPD-1/PD-L1 inhibitorsPlatinum-containing chemotherapyMetastatic urothelial cancerPD-L1 inhibitorsRECIST v1.1Investigator assessmentUrothelial cancerMicrotubule-disrupting agent monomethyl auristatin EDay 1PD-1 inhibitor pembrolizumabActive CNS metastasesCisplatin-containing therapyFirst-line patientsPrior systemic treatmentPD-L1 statusTumor response rateMonomethyl auristatin EAntibody-drug conjugatesMeasurable diseaseCNS metastasisPrimary endpointSecondary endpointsCreatinine clearanceSystemic treatmentUncontrolled diabetes
2009
Management of Diabetes and Hyperglycemia in the Hospital Setting
DeMauro-Jablonski S, Inzucchi S. Management of Diabetes and Hyperglycemia in the Hospital Setting. 2009, 773-786. DOI: 10.1007/978-0-387-09841-8_47.Peer-Reviewed Original ResearchDiabetic ketoacidosisDiabetic patientsNational hospital discharge dataNon-diabetic peersOverall diabetes prevalenceGeneral medical conditionsHospital discharge dataComplications of diabetesManagement of diabetesPrincipal diagnostic codeNew practice guidelinesHealth care systemFoot infectionsDiabetes mellitusHospitalized patientsSevere hypoglycemiaUncontrolled diabetesDiabetes prevalenceHospitalization ratesHyperglycemic syndromeKidney diseaseOutpatient settingPrimary diagnosisDiagnostic codesGlucose management
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply